Guggenheim Capital LLC increased its position in shares of Cerner Co. (NASDAQ:CERN) by 25.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,121,984 shares of the company’s stock after acquiring an additional 227,626 shares during the period. Guggenheim Capital LLC’s holdings in Cerner were worth $75,611,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of Cerner by 2.2% in the 4th quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock valued at $1,315,406,000 after purchasing an additional 420,942 shares during the period. Capital International Investors boosted its position in shares of Cerner by 0.3% in the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock valued at $345,994,000 after purchasing an additional 12,178 shares during the period. Geode Capital Management LLC boosted its position in shares of Cerner by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock valued at $252,916,000 after purchasing an additional 98,444 shares during the period. American Century Companies Inc. boosted its position in shares of Cerner by 3.7% in the 4th quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock valued at $215,949,000 after purchasing an additional 114,224 shares during the period. Finally, Legal & General Group Plc boosted its position in shares of Cerner by 1.8% in the 3rd quarter. Legal & General Group Plc now owns 1,477,451 shares of the company’s stock valued at $105,371,000 after purchasing an additional 25,842 shares during the period. 78.56% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cerner Co. (NASDAQ CERN) opened at $64.91 on Monday. The stock has a market capitalization of $21,588.89, a PE ratio of 29.24, a PEG ratio of 1.89 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01. Cerner Co. has a 1-year low of $54.49 and a 1-year high of $73.86.
Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the business posted $0.61 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. sell-side analysts anticipate that Cerner Co. will post 2.42 earnings per share for the current year.
A number of brokerages have commented on CERN. SunTrust Banks lowered Cerner from a “buy” rating to a “hold” rating in a research report on Tuesday, January 16th. They noted that the move was a valuation call. Zacks Investment Research lowered Cerner from a “buy” rating to a “hold” rating in a research report on Tuesday, January 16th. Leerink Swann restated a “hold” rating on shares of Cerner in a research report on Saturday, November 25th. Evercore ISI began coverage on Cerner in a research report on Thursday, January 18th. They set an “in-line” rating and a $77.00 price objective for the company. Finally, Stifel Nicolaus restated a “hold” rating on shares of Cerner in a research report on Wednesday, November 22nd. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $67.66.
In related news, Director William D. Zollars sold 4,100 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total value of $254,856.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of Cerner stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $64.52, for a total value of $19,852,804.00. Following the completion of the transaction, the insider now directly owns 1,229,719 shares in the company, valued at $79,341,469.88. The disclosure for this sale can be found here. Insiders sold a total of 595,800 shares of company stock worth $38,133,420 over the last three months. 13.11% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: “Cerner Co. (CERN) Shares Bought by Guggenheim Capital LLC” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/03/12/cerner-co-cern-shares-bought-by-guggenheim-capital-llc.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.